![]() |
|
|
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
![]() |
|
Human ADORA2B/Adenosine A2B Receptor | |
Rabbit | |
Human (tested or 100% immunogen sequence identity) | |
IgG Polyclonal | |
Unconjugated | |
Antiserum | |
Unmodified |
A 16 amino acid sequence corresponding to human brain A2bR gene (1). This region corresponds to the 2nd extracellular domain. A cysteine has been added at the NH2 terminus for coupling to KLH. | |
N-Terminus | |
Recognizes human Adenosine A2b Receptor. Species cross-reactivity: mouse and rat A2bR. Species sequence homology: rabbit, 87%; canine, 81%; rat, 75%; mouse, 62%. | |
Suitable for use in ELISA and Western Blot. Western Blot: 1:1000-1:5000 using ECL. ELISA: 1:10000-1:50000 using 50-100 ng A1R control peptide/well. |
PBS, 0.05% sodium azide, 40% glycerol. | |
Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles. | |
For research use only. |
ADORA2B Antibody, ADORA2 Antibody, A2b receptor Antibody, Adenosine A2b receptor Antibody, Adenosine a2b Antibody, Adenosine receptor A2b Antibody, A2b adenosine receptor Antibody
The A2b Adenosine Receptor is a target of theophylline and enprofylline in the treatment of asthma. In lung mast cells, A2b receptors are associated with the release of inflammatory mediators. They can also bind the axonal chemoattractant netrin-1 (Corset et al., 2000).